Disease patterns in pediatric classical Hodgkin lymphoma: A report from a developing area in Brazil

Hematological Oncology

Volumn 29, Issue 4, 2011, Pages 190-195

  Barros, Mário Henrique M ^a,b   Hassan, Rocio ^a   Niedobitek, Gerald ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNFALLKRANKENHAUS BERLIN   (Germany)

Author keywords

Childhood; Epstein Barr virus; Hodgkin lymphoma; Tumour microenvironment

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CHILDHOOD DISEASE; DEVELOPING COUNTRY; DISEASE COURSE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; LYMPHOCYTE-RICH CLASSICAL HODGKIN LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOCIOECONOMICS;

ADOLESCENT; AGE FACTORS; BRAZIL; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; MALE;

EID: 83555177621     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.984     Document Type: Article

References (46)

1. Kuppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998;16:471-493.
2. Swerdlow SH. International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th edn), International Agency for Research on Cancer: Lyon, France, 2008.
3. Barros MH, Scheliga A, De Matteo E, et al. Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leuk Lymphoma 2010;51(8):1513-1522.
4. Armstrong AA, Alexander FE, Cartwright R, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12(8):1272-1276.
5. Harris NL. The many faces of Hodgkin's disease around the world: what have we learned from its pathology? Ann Oncol 1998;9 (Suppl 5):S45-S56.
6. Hassan R, Klumb CE, Felisbino FE, et al. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region. Haematologica 2008;93(5):780-783.
7. Chabay PA, Barros MH, Hassan R, et al. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome.J Pediatr Hematol Oncol 2008;30(4):285-291.
8. Rappaport H, Berard CW, Butler JJ, Dorfman RF, Lukes RJ, Thomas LB. Report of the Committee on Histopathological Criteria Contributing to Staging of Hodgkin's Disease. Cancer Res 1971;31(11):1864-1865.
9. Schreck S, Friebel D, Buettner M, et al. Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Hematol Oncol 2009;27(1):31-39.
10. Claviez A, Tiemann M, Luders H, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.J Clin Oncol 2005;23(18):4048-4056.
11. Huang X, van den Berg A, Gao Z, et al. Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. PLoS ONE 2010;5(5):e10865.
12. Chang KL, Albujar PF, Chen YY, Johnson RM, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993;81(2):496-501.
13. Armstrong AA, Alexander FE, Paes RP, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993;142(6):1683-1688.
14. Razzouk BI, Gan YJ, Mendonca C, et al. Epstein-Barr virus in pediatric Hodgkin disease: age and histiotype are more predictive than geographic region. Med Pediatr Oncol 1997;28(4):248-254.
15. Zarate-Osorno A, Roman LN, Kingma DW, Meneses-Garcia A, Jaffe ES. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995;75(6):1360-1366.
16. Preciado MV, De Matteo E, Diez B, Menarguez J, Grinstein S. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Blood 1995;86(10):3922-3929.
17. Monterroso V, Zhou Y, Koo S, Glackin C, Bujan W, Medeiros LJ. Hodgkin's disease in Costa Rica: a report of 40 cases analyzed for Epstein-Barr virus. Am J Clin Pathol 1998;109(5):618-624.
18. Weinreb M, Day PJ, Niggli F, et al. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996;74(1):27-31.
19. Zhou XG, Sandvej K, Li PJ, et al. Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer 2001;92(6):1621-1631.
20. Chan JK, Yip TT, Tsang WY, Lau WH, Wong CS, Ma VW. Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 1995;26(3):314-318.
21. Liu SM, Chow KC, Chiu CF, Tzeng CH. Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 1998;83(2):367-371.
22. Huh J, Park C, Juhng S, Kim CE, Poppema S, Kim C.A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 1996;77(5):949-955.
23. Peh SC, Looi LM, Pallesen G. Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathology 1997;30(3):227-233.
24. Leoncini L, Spina D, Nyong'o A, et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996;65(6):781-784.
25. Kusuda M, Toriyama K, Kamidigo NO, Itakura H.A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan. Am J Trop Med Hyg 1998;59(5):801-807.
26. Dinand V, Dawar R, Arya LS, Unni R, Mohanty B, Singh R. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer 2007;43(1):161-168.
27. De Matteo E, Baron AV, Chabay P, Porta J, Dragosky M, Preciado MV. Comparison of Epstein-Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med 2003;127(10):1325-1329.
28. Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993;81(2):462-467.
29. Andriko JA, Aguilera NS, Nandedkar MA, Abbondanzo SL. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus. Mod Pathol 1997;10(4):366-371.
30. Weinreb M, Day PJ, Murray PG, et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.J Pathol 1992;168(4):365-369.
31. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer 1993;71(10):3124-3129.
32. Coates PJ, d'Ardenne AJ, Slavin G, Kingston JE, Malpas JS. Detection of Epstein-Barr virus in Reed-Sternberg cells of Hodgkin's disease arising in children. Med Pediatr Oncol 1993;21(1):19-23.
33. Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993;23(2):189-191.
34. Claviez A, Tiemann M, Peters J, Kreipe H, Schneppenheim R, Parwaresch R. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood. Ann Hematol 1994;68(2):61-66.
35. Kanavaros P, Sakalidou A, Tzardi M, et al. Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood. Pathol Res Pract 1994;190(11):1026-1030.
36. Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 2005;106(7):2444-2451.
37. Bigni R. Linfoma de Hodgkin. Instituto Nacional do Câncer: Rio de Janeiro;2010. [cited 2010 23/12/2010]; Available from:.
38. Vassallo J, Paes RP, Soares FA, et al. Histological classification of 1, 025 cases of Hodgkin's lymphoma from the State of Sao Paulo. Brazil. Sao Paulo Med J 2005;123(3):134-136.
39. Araujo I, Bittencourt AL, Barbosa HS, et al. The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil. Virchows Arch 2006;449(3):315-319.
40. Carvalho RP, Evans AS, Pannuti CS, Frost P, Grossman L, Jamra MA. EBV infections in Brazil. III-Infections mononucleosis. Rev Inst Med Trop Sao Paulo 1981;23(4):167-172.
41. Figueira-Silva CM, Pereira FE. Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitoria, State of Espirito Santo, Brazil. Rev Soc Bras Med Trop 2004;37(5):409-412.
42. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108(12):3786-3791.
43. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al. Age-related changes in human blood lymphocyte subpopulations.J Pediatr 1992;120(2 Pt 1):216-222.
44. Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr 1992;81(2):125-132.
45. Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 2005;1:231-238.
46. Black FL, Hierholzer WJ, Pinheiro F, et al. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol 1974;100(3):230-250.